Sidebar Ads

Tuesday, February 12, 2019

Better Buy: Gilead Sciences vs. Pfizer


Better Buy: Gilead Sciences vs. Pfizer



Which of these drugmakers will push your portfolio higher in the years ahead?

0 comments:

Post a Comment

Mick Lynch announces retirement as head of RMT

Mr Lynch steered the union through fierce pay strikes in 2022 and 2023 before securing a new deal. from BBC News https://ift.tt/r59DYT1